BRIEF-EMA Says Recommended Authorising Use Of Nuvaxovid As Booster Dose

BRIEF-EMA Says Recommended Authorising Use Of Nuvaxovid As Booster Dose

European Medicines Agency:

* EMA: EMA'S CHMP RECOMMENDED AUTHORISING THE USE OF NUVAXOVID AS A BOOSTER DOSE FOR ADULTS WHO HAVE RECEIVED THE SAME OR ANOTHER COVID-19 VACCINE FOR THEIR INITIAL VACCINATION: 01/09/2022

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.